跳至主要内容
临床试验/CTRI/2010/091/000279
CTRI/2010/091/000279已完成3 期

A Comparative, Randomized, Double blind, Multicentric, Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Besifloxacin ophthalmic suspension 0.6% Vs Moxifloxacin ophthalmic solution 0.5% in patients with Bacterial conjunctivitis.

Ajanta Pharma Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Must have a diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye.
  • 2. Patients providing written informed consent to participate in the trial.

排除标准

  • 1. Patients < 18 & > 60 years.
  • 2. Pregnant or nursing females
  • 3. Known hypersensitivity to fluroquinolones or to any of the study ingredients.
  • 4. Use of any antibiotic within 72 hours of treatment.
  • 5. Any disease or condition that could interfere with the safety and efficacy evaluations of the study medications.
  • 6. Participation in an ophthalmic drug or device research study within 30 days prior to entry into the study.

研究者

相似试验